Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Giralt

Showing results (31-40 of 176) with videos related to

Pageof 18
Sort By:
Hematology (Amsterdam, Netherlands)|June 15, 2007
Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myelomaM Wang, S Giralt, K Delasalle, et al.
American Journal of Hematology|January 10, 1998
Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: review of forty casesD Przepiorka, S Giralt, I Khouri, et al.
Bone Marrow Transplantation|June 1, 2004
Clinical outcomes with intensive therapy for patients with primary resistant multiple myelomaR Alexanian, D Weber, K Delasalle, et al.
Cancer|October 24, 2000
Therapeutic choices in younger patients with chronic myelogenous leukemiaH M Kantarjian, F J Giles, S O'Brien, et al.
Bone Marrow Transplantation|December 12, 2002
Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?G Hale, S Slavin, J M Goldman, et al.
Bone Marrow Transplantation|July 5, 2001
Impact of complete remission with intensive therapy in patients with responsive multiple myelomaR Alexanian, D Weber, S Giralt, et al.
Bone Marrow Transplantation|September 1, 1996
Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemiaG Rondón, S Giralt, Y Huh, et al.
The American Journal of Medicine|July 1, 1994
Philadelphia-chromosome-positive adult acute lymphocytic leukemia: characteristics, treatment results, and prognosis in 41 patientsH A Preti, S O'Brien, S Giralt, et al.
British Journal of Haematology|May 1, 1997
Collection of peripheral blood stem cells from normal donors 60 years of age or olderP Anderlini, D Przepiorka, J Lauppe, et al.
Addictive Behaviors|May 15, 2016
Free-to-play: About addicted Whales, at risk Dolphins and healthy Minnows. Monetarization design and Internet Gaming DisorderM Dreier, K Wölfling, E Duven, et al.
Pageof 18

Showing results (31-40 of 176) with videos related to

Sort By:
Pageof 18
Hematology (Amsterdam, Netherlands)|June 15, 2007
Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myelomaM Wang, S Giralt, K Delasalle, et al.
American Journal of Hematology|January 10, 1998
Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: review of forty casesD Przepiorka, S Giralt, I Khouri, et al.
Bone Marrow Transplantation|June 1, 2004
Clinical outcomes with intensive therapy for patients with primary resistant multiple myelomaR Alexanian, D Weber, K Delasalle, et al.
Cancer|October 24, 2000
Therapeutic choices in younger patients with chronic myelogenous leukemiaH M Kantarjian, F J Giles, S O'Brien, et al.
Bone Marrow Transplantation|December 12, 2002
Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?G Hale, S Slavin, J M Goldman, et al.
Bone Marrow Transplantation|July 5, 2001
Impact of complete remission with intensive therapy in patients with responsive multiple myelomaR Alexanian, D Weber, S Giralt, et al.
Bone Marrow Transplantation|September 1, 1996
Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemiaG Rondón, S Giralt, Y Huh, et al.
The American Journal of Medicine|July 1, 1994
Philadelphia-chromosome-positive adult acute lymphocytic leukemia: characteristics, treatment results, and prognosis in 41 patientsH A Preti, S O'Brien, S Giralt, et al.
British Journal of Haematology|May 1, 1997
Collection of peripheral blood stem cells from normal donors 60 years of age or olderP Anderlini, D Przepiorka, J Lauppe, et al.
Addictive Behaviors|May 15, 2016
Free-to-play: About addicted Whales, at risk Dolphins and healthy Minnows. Monetarization design and Internet Gaming DisorderM Dreier, K Wölfling, E Duven, et al.
Pageof 18